These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 38509503
1. Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study. Ikuma S, Akatsuka J, Takeda H, Endo Y, Kiriyama T, Hamasaki T, Kimura G, Kondo Y. BMC Urol; 2024 Mar 20; 24(1):63. PubMed ID: 38509503 [Abstract] [Full Text] [Related]
3. Novel utility of Vesical Imaging-Reporting and Data System in multimodal treatment for muscle-invasive bladder cancer. Kimura K, Yoshida S, Tsuchiya J, Kitazume Y, Waseda Y, Tanaka H, Yokoyama M, Toda K, Yoshimura R, Masaya I, Koga F, Tateishi U, Fujii Y. Eur Radiol; 2023 Sep 20; 33(9):6245-6255. PubMed ID: 37045982 [Abstract] [Full Text] [Related]
4. Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the Vesical Imaging-Reporting and Data System. Arita Y, Kwee TC, Woo S, Shigeta K, Ishii R, Okawara N, Edo H, Waseda Y, Vargas HA. Eur Urol Focus; 2024 Jan 20; 10(1):131-138. PubMed ID: 37633790 [Abstract] [Full Text] [Related]
9. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application. Makboul M, Farghaly S, Abdelkawi IF. Br J Radiol; 2019 Dec 20; 92(1104):20190401. PubMed ID: 31573328 [Abstract] [Full Text] [Related]
10. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology. Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii Y, Jinzaki M. Eur Urol Oncol; 2023 Feb 20; 6(1):99-102. PubMed ID: 35933266 [Abstract] [Full Text] [Related]
11. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer. Erkoc M, Otunctemur A, Bozkurt M, Can O, Atalay HA, Besiroglu H, Danis E, Degirmentepe RB. Int J Clin Pract; 2021 Sep 20; 75(9):e14584. PubMed ID: 34185372 [Abstract] [Full Text] [Related]
14. Is high accuracy of Vesical Imaging-Reporting and Data System (VI-RADS) sufficient for its implementation in the urological practice? Rysankova K, Hanzlikova P, Zidlik V, Vrtkova A, Slisarenko M, Skarda J, Grepl M, Krhut J. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar 20; 167(1):85-90. PubMed ID: 36628563 [Abstract] [Full Text] [Related]
15. Combining volumetric apparent diffusion coefficient histogram analysis with vesical imaging reporting and data system to predict the muscle invasion of bladder cancer. Li S, Liang P, Wang Y, Feng C, Shen Y, Hu X, Hu D, Meng X, Li Z. Abdom Radiol (NY); 2021 Sep 20; 46(9):4301-4310. PubMed ID: 33909091 [Abstract] [Full Text] [Related]
18. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study. Kazan O, Gunduz N, Bakir B, Iplikci A, Culpan M, Ersoy B, Yildirim A. Actas Urol Esp (Engl Ed); 2023 Dec 20; 47(10):638-644. PubMed ID: 37209783 [Abstract] [Full Text] [Related]